Want to join the conversation?
$AGN said YTD it has achieved 13 major pharma and device approvals. The company has also achieved 9 major regulatory submissions with 3 major submissions in 2Q16. $AGN obtained approvals globally to further enhance its medical study franchise including JUVEDERM VOLBELLA for lip augmentation and correction of perioral lines in adults in the US.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!